Spyre Therapeutics SYRE
NASDAQ SYRE
$93.19 +3.26 (+3.63%)
At close: Oct 2, 2026 · 4:00 PM EDT

Spyre Therapeutics (SYRE) Property, Plant & Equipment (Net) (2015 - 2023)

Updated

Spyre Therapeutics (SYRE) posted Property, Plant & Equipment (Net) of $3.42 million for Q1 2023, down 19.1% from $4.23 million a year earlier but up 6.3% from the prior quarter.

Analysis

Spyre Therapeutics (SYRE) Property, Plant & Equipment (Net) (2015 - 2023) Analysis & Trends

At the end of FY2022, Spyre Therapeutics' Property, Plant & Equipment (Net) came in at $3.22 million, down 29.2% from FY2021.

  • Annual Property, Plant & Equipment (Net) shows a five-year compound annual growth rate of 30.4% (FY2017 to FY2022).
  • In prior years, Spyre Therapeutics' Property, Plant & Equipment (Net) was $4.55 million in FY2021 (-19.4%), $5.64 million in FY2020 (+136.6%), $2.39 million in FY2019 (+134.3%) and $1.02 million in FY2018 (+19.2%).
  • Quarterly Property, Plant & Equipment (Net) has run from a low of $776,000 in Q2 2018 to a high of $5.64 million in Q4 2020 over five years.
  • On a year-over-year basis, Property, Plant & Equipment (Net) has declined in each of the last seven quarters, with an average decline of 17.9% over the last eight quarters.
  • The strongest year-over-year quarter for Property, Plant & Equipment (Net) in the past five years was Q3 2020, with growth of 432.2%; the weakest was Q4 2022, with a decline of 29.2%.
  • According to Business Quant data, Property, Plant & Equipment (Net) for the three prior quarters was $3.22 million (Q4 2022), $3.56 million (Q3 2022) and $3.89 million (Q2 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 29.29 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 23.58 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 5.80 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 25.74 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 10.69 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 13.62 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 8.55 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 5.83 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 19.03 Bn
10 Spyre Therapeutics 8.21 Bn 8.21 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 3.42 Mn
Dec 31, 2022 3.22 Mn
Sep 30, 2022 3.56 Mn
Jun 30, 2022 3.89 Mn
Mar 31, 2022 4.23 Mn
Dec 31, 2021 4.55 Mn
Sep 30, 2021 4.92 Mn
Jun 30, 2021 5.21 Mn
Mar 31, 2021 5.52 Mn
Dec 31, 2020 5.64 Mn
Sep 30, 2020 5.22 Mn
Jun 30, 2020 4.90 Mn
Mar 31, 2020 4.24 Mn
Dec 31, 2019 2.39 Mn
Sep 30, 2019 980,000.00
Jun 30, 2019 921,000.00
Mar 31, 2019 952,000.00
Dec 31, 2018 1.02 Mn
Sep 30, 2018 846,000.00
Jun 30, 2018 776,000.00
API Access

Spyre Therapeutics Property, Plant & Equipment (Net) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=SYRE&period=max&api_key=YOUR_API_KEY